Apr 17, 2017
Prima BioMed Receives Approval for Third Cohort of Phase I Melanoma Trial
Apr 11, 2017
Prima BioMed receives A$492,144 Tax Refund from Australian Government
Mar 15, 2017
Prima BioMed Completes Recruitment for Second Patient Cohort in Melanoma Trial and Will Present at ICI Conference in Boston
Mar 01, 2017
USA Patent Grants for IMP321 in Cancer
Feb 24, 2017
First Half 2017 Operational Update
